|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In vivo phage display selection in the human/SCID mouse chimera model for defining synovial specific determinants显示文摘 | Lee L Garrood T Pitzalis C | 2007 | Methods Mol Med2007，136，3： | 1 |
| 2 | Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation triaI显示文摘 | Choy EH Isenberg DA Garrood T | 2002 | Arthritis Rheum2002，46，12： | 1 |
| 3 | Therapeuticbenefit of blocking interleukin-6 activity w ith an anti-in-terleukin-6 receptor monoclonal antibody in rheumatoidarthritis:a randomized,doubleblind,placebo-con-trolled,dose-escalation trial显示文摘 | Choy E H Isenberg D A Garrood T | 2002 | Arthritis Rheum2002，46，12： | 1 |
| 4 | Development of a novelrecombinant biotherapeutic with applications in targeted therapyof human arthritis显示文摘 | Kamperidis P Kamalati T Ferrari M Jones M Garrood T Smith MD Diez-Posada S Hughes C Finucane C MatherS Nissim A George AJ Pitzalis C | 2011 | Arthritis Rheum2011，63，12： | 1 |
| 5 | Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalafion trial显示文摘 | Choy E H Isenberg D A Garrood T | 2002 | Arthritis Rheum2002，46，12： | 1 |
| 6 | Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis:a randomized,double-blind,placebo-controlled,dose-escalation trial显示文摘 | Choy EHl Isenberg DA Garrood T | 2002 | Arthritis Rheum2002，46，12： | 1 |
| 7 | Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatiod arthritis : a randomized, double-blind, placebo- controlled, dose-escalation trial 显示文摘 | Choy EH Isenberg DA Garrood T | 2002 | Arthritis Rheum2002，46，： | 1 |
| 8 | Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis:a randomized,double-blind,placebo-controlled,dose-escalation trial显示文摘 | Choy EH Isenberg DA Garrood T | | 0，，： | 1 |
| 9 | Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, doub- le-blind, placebo-controlled, dose-escalation trial 显示文摘 | Choy EH lsenberg DA Garrood T | 2002 | Arthritis Rheum2002，46，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员